Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860493 · ClinicalTrials.gov registry record
Feasibility of the IC-Flow Device for Fluorescent Perfusion Evaluation During Feasibility of the IC-Flow Device
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 6
- Enrollment target
NCT03860493 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 6 participants.
The verdict
NCT03860493 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
1. Primary Objective: Demonstrate that the IC-Flow Imaging device with Indocyanine Green (ICG) is a feasible technique when visualizing and identifying perfusion of organs when compared to The KARL STORZ VITOM II ICG System during open reconstructive surgical procedures 2. Secondary Objective: 1. Evaluate the mean Assessment of handling properties using The IC- Flow versus The VITOM II. 2. Evaluate the mean Surgeon preference Level using The IC- Flow tower, The IC-Flow Hand-held device versus The VITOM II.
Interventions
- PROCEDURE Perfusion evaluation with indocyanine green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03860493
The ClinicalTrials.gov registry entry for NCT03860493 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perfusion evaluation with indocyanine green is the first listed.
NCT03860493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03860493 about?
NCT03860493 is a clinical study titled "Feasibility of the IC-Flow Device for Fluorescent Perfusion Evaluation During Feasibility of the IC-Flow Device". 1. Primary Objective: Demonstrate that the IC-Flow Imaging device with Indocyanine Green (ICG) is a feasible technique when visualizing and identifying perfusion of organs when compared to The KARL STORZ VITOM II ICG System during open reconstructive surgical procedures 2. Secondary Objective: ...
What is the current status of trial NCT03860493?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-05-15. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03860493?
The interventions under investigation include: Perfusion evaluation with indocyanine green (PROCEDURE).
Who is sponsoring clinical trial NCT03860493?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.